CCMW
MBIO icon

Cypress Capital Management (Wyoming)’s Mustang Bio MBIO Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4
Closed -$4K – 240
2021
Q4 		$4K Hold
4
– – ﹤0.01% 235
2021
Q3 		$8K Hold
4
– – 0.01% 194
2021
Q2 		$10K Hold
4
– – 0.01% 223
2021
Q1 		$10K Hold
4
– – 0.01% 207
2020
Q4 		$11K Buy
+4
New +$9.56K 0.01% 173

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s MBIO Position: Q1 2022 in Review

Cypress Capital Management (Wyoming) sold out of Mustang Bio (MBIO) in Q1 2022, closing a stake of 4 shares — an estimated $4K sold.

Cypress Capital Management (Wyoming) first reported a position in MBIO in Q4 2020 and held it in 5 quarters. The position peaked at $11K in Q4 2020. 81 funds tracked by Wall St. Rank hold MBIO as of Q1 2022.

  • Cypress Capital Management (Wyoming) reported no remaining Mustang Bio position as of Q1 2022 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 4 Mustang Bio shares in Q1 2022, an estimated $4K.
  • Cypress Capital Management (Wyoming) first reported a position in Mustang Bio in Q4 2020 and held it in 5 quarters.
  • Cypress Capital Management (Wyoming)'s Mustang Bio position peaked at $11K in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2022.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q1 2022, filed 9 May 2022.